Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor

Details for Australian Patent Application No. 2005223351 (hide)

Owner Glaxo Group Limited

Inventors Christensen IV, Siegfried Benjamin; Trottet, Lionel; Trivedi, Naimisha; Edlin, Christopher David; Cook, Caroline Mary; Jones, Paul Spencer; Sayani, Amyn Pyarali; Johnson, Martin Redpath; Lindvall, Mika Kristian

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005223351

PCT Pub. Number WO2005/090352

Priority 0505214.7 14.03.05 GB; 0405893.9 16.03.04 GB

Filing date 15 March 2005

Wipo publication date 29 September 2005

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090352 Priority application(s): WO2005/090352

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223352-Novel Tat complexes, and vaccines comprising them

2005223349-Microcoating comprising siloxanes